ENDRA Life Sciences Inc. (NDRA)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | — | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-31) · 99.1 | ||
| 10-Q | Q3-2025 | — | ||
| 10-Q | Q2-2025 | 8-K (2025-07-09) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-15) · 99.1 | ||
| 10-K/A | FY-2024 | |||
| 10-K | FY-2024 | 8-K (2025-03-31) · 99.1 · 99.2 | ||
| 10-Q/A | Q3-2024 | |||
| 10-Q | Q3-2024 | 8-K (2024-11-15) · 99.1 | 8-K (2024-08-23) · 99.1 · 99.2 | ||
| 10-Q | Q2-2024 | — | ||
| 10-Q | Q1-2024 | 8-K (2024-05-14) · 99.1 | 8-K (2024-05-10) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-03-28) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-14) · 99.1 | ||
| 10-Q | Q2-2023 | 8-K (2023-08-14) · 99.1 · 99.2 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Audit Information | — |
|
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations | ||
| Consolidated Statements of Stockholders Equity | ||
| Consolidated Statements of Cash Flows | ||
| Notes | ||
| Accounts Payable and Accrued Liabilities | ||
| Bank Loans | ||
| Capital Stock | ||
| Commitments and Contingencies | ||
| Common Stock Options | — |
|
| Common Stock Options and Restricted Stock | ||
| Common Stock Options, Restricted Stock Units and Restricted Stock | — |
|
| Common Stock Options, Restricted Stuck Units and Restricted Stock | — |
|
| Common Stock Warrants | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Digital Assets | ||
| Fixed Assets | ||
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Inventory | ||
| Nature of The Business | ||
| Pay Vs Performance Disclosure | ||
| Related Party Transactions | ||
| Segment Reporting | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | — |
|
| Summary of Significant Accounting Policies and Going Concern | — |
|